Medicinal composition for treating cervical cancer, and preparation method, preparation and application of medicinal composition

Abstract

The invention discloses a pharmaceutical composition for treating cervical cancer, its preparation method, preparation and application. The pharmaceutical composition for treating cervical cancer comprises raw materials in parts by weight of 30-70 parts of rehmannia glutinosa, 20-40 parts of rehmannia glutinosa, 30-70 parts of Poria cocos, 20-50 parts of Alisma, 20-50 parts of cornus, 50 parts of tortoise shell ~15 parts, 10~30 parts of Ligustrum lucidum, 5~15 parts of Digupi, 5~15 parts of paeonol, 20~40 parts of medlar, 20~40 parts of dodder, 8~20 parts of Chuan Duan, 20~ of Chinese yam 40 parts, 20~40 parts of Scutellaria barbata, 8~20 parts of white snake grass, 5~15 parts of raw Wulingzhi, 5~15 parts of raw black petunia, 5~15 parts of raw aconite, 5 parts of raw Guangmuxiang ~15 servings. The preparation is tablet, powder, capsule, granule and pill prepared by adding pharmaceutically acceptable auxiliary materials to the pharmaceutical composition for treating cervical cancer. The application is the application of the pharmaceutical composition for treating cervical cancer in the preparation of medicines for treating cervical cancer. All medicines of the present invention are combined, act synergistically, and cure cervical cancer mainly.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating cervical cancer, a preparation method, preparation and application thereof. Background technique [0002] Cervical cancer is the most common gynecological malignancy. The high-incidence age of carcinoma in situ is 30-35 years old, and that of invasive carcinoma is 45-55 years old. In recent years, the onset tends to be younger. The widespread application of cervical cytology screening in recent decades has enabled early detection and treatment of cervical cancer and precancerous lesions, and the incidence and mortality of cervical cancer have dropped significantly. Early cervical cancer often has no obvious symptoms and signs, and the cervix may be smooth or difficult to distinguish from cervical columnar heterotopia. Patients with cervical canal are easily missed or misdiagnosed because of the normal appearance of the cerv...

AI Technical Summary

Problems solved by technology

At present, there are many kinds of drugs for the treatment of cervical cancer, but all of them have relatively large side effects, it is difficult to control the suitability of individual drug selection, and the risk of changing drugs is very high. Therefore, it is necessary to develop a drug that can solve the above problems and meet the treatment needs of patients with cervical cancer. is very necessary